Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...

MiRXES Co-Founder & CEO Lihan Zhou says the Chinese market is key, as it gives his company the scale to bring down cost. The Singapore-based biotechnology startup made its Hong Kong initial public ...

The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...

President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying ...

Rapper Kid Cudi told a jury Sean "Diddy" Combs broke into his Los Angeles home after the hip-hop mogul found out he was ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...

Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...

Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

Newsday Zimbabwe ZIMBABWE’S scientific and academic landscape is set for a major transformation as France will today hand ...